CELL FORGE 1 Trademark

Trademark Overview

On Thursday, April 22, 2021, a trademark application was filed for CELL FORGE 1 with the United States Patent and Trademark Office. The USPTO has given the CELL FORGE 1 trademark a serial number of 90663475. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 29, 2024. This trademark is owned by Allogene Therapeutics, Inc.. The CELL FORGE 1 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
cell forge 1

General Information

Serial Number90663475
Word MarkCELL FORGE 1
Filing DateThursday, April 22, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 1, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
Pseudo MarkCELL FORGE ONE
NOT AVAILABLE"CELL"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 29, 2021
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameAllogene Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, US 94080
Party NameAllogene Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, US 94080

Trademark Events

Event DateEvent Description
Monday, April 26, 2021NEW APPLICATION ENTERED
Thursday, September 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 16, 2021ASSIGNED TO EXAMINER
Wednesday, December 29, 2021ASSIGNED TO LIE
Monday, December 20, 2021NON-FINAL ACTION WRITTEN
Monday, December 20, 2021NON-FINAL ACTION E-MAILED
Monday, December 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 28, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 28, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, December 28, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, December 28, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 12, 2022SOU TEAS EXTENSION RECEIVED
Monday, September 12, 2022SOU EXTENSION 1 FILED
Monday, September 12, 2022SOU EXTENSION 1 GRANTED
Thursday, January 19, 2023SOU EXTENSION 2 GRANTED
Wednesday, September 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 19, 2023SOU EXTENSION 2 FILED
Monday, April 29, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, April 29, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Saturday, January 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 13, 2023SOU EXTENSION 3 FILED
Wednesday, September 13, 2023SOU EXTENSION 3 GRANTED
Friday, September 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

forge cell preparations pharmaceutical including therapy immunotherapy tumors namely treatment cancer